share_log

KP Tissue Announces Senior Unsecured Notes Financing and Intention to Redeem 6.00% Notes Due April 2025

KP Tissue Announces Senior Unsecured Notes Financing and Intention to Redeem 6.00% Notes Due April 2025

KP Tissue宣布发行无抵押高级票据融资,并打算赎回于2025年4月到期的6.00%票据
GlobeNewswire ·  10/26 07:06

NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN U.S. OR FOR DISSEMINATION IN U.S.

不得向美国新闻社或在美国传播。

MISSISSAUGA, Ontario, Oct. 25, 2024 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that Kruger Products Inc. ("KPI") has, pursuant to an underwriting agreement entered into today, agreed to issue and sell CDN $135 million principal amount of 6.625% Senior Unsecured Notes (the "Notes") due November 1, 2031 by way of private placement (the "Offering"). Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing on May 1, 2025.

安大略省密西沙加,2024年10月25日(环球新闻社) - KP Tissue Inc.(KPT)(TSX:KPT)今天宣布,Kruger Products Inc.(“KPI”)已根据今天签订的承销协议同意发行和卖出加元$13500万的6.625%未担保高级票据(“票据”),到期日为2031年11月1日,通过定向增发(“发行”)。票据的利息每年5月1日和11月1日按年付息。2025年5月1日起计息。

Scotia Capital Inc., National Bank Financial Inc., CIBC Capital Markets Inc. and TD Securities Inc. are acting as joint book-running managers for the Offering. The Offering is expected to close on November 1, 2024, subject to customary closing conditions. KPI intends to use the net proceeds of the Offering to redeem all of KPI's outstanding 6.00% senior unsecured notes due April 24, 2025 (the "2025 Notes") and for general corporate purposes. KPI intends to deliver today a notice of redemption of the 2025 Notes with a redemption date of November 12, 2024 subject to the closing of the Offering prior to that date.

Scotia Capital Inc.、national bank、CIBC Capital Markets Inc.和TD Securities Inc.将作为本次发行的联席主承销商。该发行预计将于2024年11月1日结束,视情况而定。KPI打算使用本次发行的净收益赎回KPI尚未偿还的6.00%到期于2025年4月24日的未担保高级票据(“2025年票据”),并用于一般企业用途。KPI打算今天发布2025年票据的赎回通知,赎回日期为2024年11月12日,视发行截止日是否早于该日期而定。

The Notes will be unsecured obligations of KPI and unconditionally guaranteed, jointly and severally, by certain subsidiaries of KPI, being the same guarantors as under KPI's syndicated credit facility. The Notes will rank senior in right of payment to all existing and future subordinated indebtedness of KPI and equal in right of payment to all indebtedness of KPI that is not subordinated in right of payment to the Notes other than any indebtedness that ranks senior to the Notes by operation of law.

票据将为KPI的无担保债务,由KPI的某些子公司共同且无条件担保。这些子公司与KPI的银团信贷机构一样担保。票据将在支付权利上优于KPI现有和未来的所有次级债务,并在支付权利上与所有不作为票据次级债务的KPI债务平齐,除了根据法律规定优先于票据的任何债务。

The offer and sale of the Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws, and the Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. The Notes have not been and will not be qualified for sale to the public under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada will be made on a basis exempt from the prospectus requirements of such securities laws.

票据的发行和销售未受到并将不受到根据1933年修正案("证券法")以及适用州证券法进行注册,并且未经注册或具有适用的豁免登记要求的情况下,不得在美国提供或销售票据或适用的州证券法。票据未经过且不会符合根据适用的加拿大证券法向公众销售的资格,因此,在加拿大对票据的任何提供和销售将在免于此类证券法的概要要求的基础上进行。

This news release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such offer, solicitation, purchase or sale would be unlawful. This news release does not constitute a notice of redemption of the 2025 Notes.

本新闻稿不构成要约出售或购买,或要约出售或购买票据,也不构成要约出售或购买的邀请。在任何此类要约、邀请、购买或销售将是非法的司法管辖区中,将不会进行任何要约、邀请、购买或销售。本新闻稿不构成2025票据赎回通知。

About KP Tissue Inc.
KPT was created to acquire, and its business is limited to holding, a limited equity interest in KPI, which is accounted for as an investment on the equity basis. KPT currently holds a 12.56% interest in KPI. For more information visit .

关于KP Tissue Inc.
KPt成立旨在收购,并且其业务仅限于持有KPI的有限股权,KPI被按照权益法上的投资进行核算。KPt目前持有KPI的12.56%的股权。欲了解更多信息,请访问。

About Kruger Products Inc.
KPI is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. KPI serves the Canadian consumer market with such well-known brands as Cashmere, Purex, SpongeTowels, Scotties, White Swan and Bonterra. In the U.S., KPI manufactures the White Cloud brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. KPI has approximately 2,800 employees and operates ten FSC COC-certified (FSC C-104904) production facilities in North America. For more information visit .

关于Kruger Products Inc.
KPI是加拿大领先的生产优质家庭、工业和商业用纸产品的制造商。KPI以Cashmere、Purex、SpongeTowels、Scotties、White Swan和Bonterra等知名品牌服务加拿大消费市场。在美国,KPI生产White Cloud品牌,以及许多自有品牌产品。离家使用部门向各种商业和公共机构提供高质量、具有成本效益的产品解决方案。KPI拥有约2,800名员工,并在北美运营十家FSC COC认证(FSC C-104904)生产设施。欲了解更多信息,请访问。

Forward Looking Information
Certain information included herein is forward looking, within the meaning of applicable Canadian securities laws. Such information is typically identified by words such as "anticipate", "believe", "could", "estimate", "expect", "plan", "intend", "forecast", "future", "guidance", "may", "predict", "project", "should", "strategy", "target", "will" or similar expressions suggesting future outcomes. Forward looking information in this news release includes the expected closing date of the Offering, the use of net proceeds of the Offering, the delivery of a notice of redemption of the 2025 Notes and the expected redemption date. KPT believes the expectations reflected in such forward looking information are reasonable, but no assurance can be given that these expectations will prove to be correct, and such information should not be unduly relied upon.

前瞻性信息
此处包含的部分信息属于前瞻性信息,符合适用加拿大证券法的含义。此类信息通常由诸如"预计"、"相信"、"可能"、"估计"、"期望"、"计划"、"打算"、"预测"、"未来"、"指导"、"可能"、"预测"、"计划"、"策略"、"目标"、"将"等词语识别,暗示未来结果。本新闻稿中的前瞻性信息包括定向增发的预期截止日期、定向增发净收益的使用、2025年债券赎回通知的交付以及预期赎回日期。KPt相信,此类前瞻性信息所反映的期望是合乎情理的,但不能保证这些期望将被证明是正确的,因此不应过分依赖此类信息。

Forward looking information is not a guarantee of future performance. By its very nature, forward looking information involves inherent assumptions, risks and uncertainties, both general and specific, and risks that predictions, forecasts, projections and other forward looking information will not be achieved. These risks include, but are not limited to, risks associated with the ability to satisfy the closing conditions of the Offering. Should one or more of these risks and uncertainties materialize, or should assumptions described above prove incorrect, KPT's actual performance and results in future periods may differ materially from any projections of future performance or results expressed in or implied by such forward looking information. We caution readers not to place undue reliance on such information as a number of important factors could cause the actual results to differ materially from the beliefs, plans, objectives, expectations and anticipations, estimates and intentions expressed in such forward looking information.

前瞻性信息并非未来业绩的保证。由于其本质,前瞻性信息涉及固有的假设、一般和特定风险和不确定性,以及预测、展望、投影和其他前瞻性信息将无法实现的风险。这些风险包括但不限于与满足定向增发的关闭条件的风险相关联。如果其中一个或多个风险和不确定性实现,或者上述假设被证明不正确,KPT未来期间的实际业绩和结果可能会与前瞻性信息中表达或暗示的任何未来业绩或结果的预测实质上不同。我们提醒读者不要过分依赖此类信息,因为许多重要因素可能导致实际结果与前瞻性信息中表达的信念、计划、目标、期望和预期、估计和意图实质上不同。

Forward looking information contained in this news release is provided for the purpose of providing information about management's goals, plans and range of expectations for the future and may not be appropriate for other purposes. Any forward looking information is made as of the date hereof and, except as required by law, KPT does not undertake any obligation to publicly update or revise such information to reflect new information, subsequent or otherwise.

本新闻稿中包含的前瞻性信息旨在提供有关管理层目标、计划和未来预期范围的信息,可能不适用于其他目的。任何前瞻性信息均截至本日期发布,并且除非法律要求,KPt不承担公开更新或修订此类信息以反映新信息的义务。

INFORMATION: INVESTORS:
François Paroyan Doris Grbic
General Counsel and Corporate Secretary Director, Investor Relations
KP Tissue Inc. KP Tissue Inc.
905-812-6936 905-813-5063
francois.paroyan@krugerproducts.ca ir@krugerproducts.ca
信息: 投资者:
François Paroyan Doris Grbic
总法律顾问兼公司秘书。 投资者关系董事
KP Tissue Inc. KP Tissue Inc.
905-812-6936 905-813-5063
francois.paroyan@krugerproducts.ca ir@krugerproducts.ca

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发